10 Biotech Stocks Expected to at Least Double

The following 10 biotech stocks, though exceptionally risky, are expected to double, triple or quadruple in the next 12 months.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!